Entering text into the input field will update the search result below

Evofem Biosciences' (EVFM) CEO Saundra Pelletier on Q4 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Evofem Biosciences, Inc. (EVFM) Q4 2021 Earnings Conference Call March 4, 2022 4:30 PM ET

Company Participants

Amy Raskopf – Vice President-Investor Relations

Saundra Pelletier – Chief Executive Officer, President and Executive Director

Jay File – Chief Financial Officer

Conference Call Participants

David Amsellem – Piper Sandler

Ram Selvaraju – H.C. Wainwright

Jeff Hung – Morgan Stanley


Thank you for standing by, and welcome to the Evofem Biosciences’ Fourth Quarter and Year-End 2021 Results Conference Call. [Operator Instructions] As a reminder today's conference call is being recorded.

I would now like to turn the conference over to your host, Ms. Amy Raskopf, Vice President of Investor Relations. Ma'am, you may begin.

Amy Raskopf

Thank you, Valerie. Good afternoon, everyone, and welcome to the Evofem Biosense Q4 and year-end 2021 results call. If you haven't done so already, I encourage you to access the press release we issued this afternoon and slides that accompany this call, both of which are at evalem.com under the Investors tab.

Before we begin, I would like to remind you that remarks made on this call will contain forward-looking statements, which are made only as of today, March 3, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q.

With that, I'll turn the call over to Evofem's CEO, Saundra Pelletier.

Saundra Pelletier

Thank you, Amy. And I want to thank everyone for joining us today on the call. Evofem delivered strong growth in the fourth quarter of 2021. Net product sales of Phexxi for hormone-free birth control more than doubled in Q4. It increased 109% to $3.6 million. This reflects the hard work of our sales organization, the impact of our innovative marketing campaigns and ongoing gross to net

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.